Oretic, Copalia hct(hydrochlorothiazide)
/ Hydrochlorothiazide, Actelsar, Aldactazide, Aldoril, Amlodipine Besylate / Hydrochlorothiazide / Olmesartan Medoxomil, Amlodipine Besylate / Hydrochlorothiazide / Valsartan, Amturnide, Atacand, Avalide, Benicar, Cam-ap-es, CoAprovel, Copalia, Dafiro, Diovan, Dutoprol, Esimil, Exforge, H.r, Hydra-zide, Hydrap-es, Hydro-reserp, Hydro-serp, Hydrochlorothiazide, Hydrochlorothiazide /, Hydrochlorothiazide / Irbesartan, Hydrochlorothiazide / Olmesartan Medoxomil, Hydrochlorothiazide / Valsartan, Hydropres, Hydroserpine (r), Hyzaar, Ifirmacombi, Inderide, Inderide-, Inzirqo, Irbesartan / Hydrochlorothiazide, Karvezide, Kinzalkomb, Lopressor, Lotensin, Maxzide, Micardis, Microzide, Normozide, Oreticyl, PritorPlus, Rasilez, Rasitrio, Riprazo, Ser-a-gen, Ser-ap-es, Serpasil-esidrix, Sprimeo, Tekturna, Teveten, Timolide, Tolucombi, Trandate, Tribenzor, Unipres, Vaseretic, Viskazide, Zestoretic, Ziac (hydrochlorothiazide) is a small molecule pharmaceutical. Hydrochlorothiazide was first approved as Moduretic 5-50 on 1982-01-01. It is used to treat edema, heart failure, hypertension, and nephrotic syndrome in the USA. It has been approved in Europe to treat essential hypertension and hypertension. The pharmaceutical is active against solute carrier family 12 member 3.
Download report
Favorite
Events Timeline
Commercial
Clinical
Drug
Target
Variants
Financial
Trends
Safety
Events Timeline
5D
1M
3M
6M
YTD
1Y
2Y
5Y
Max
Events
FDA approval date
EMA approval date
Patent expiration date
Study first post date
Last update post date
Start date
Primary completion date
Completion date
Results first post date
Mock data
Subscribe for the real data
Subscribe for the real data
Commercial
Therapeutic Areas
Trade Name
FDA
EMA
Hydrochlorothiazide, Inzirqo, Microzide (discontinued: Esidrix, Hydro, Hydrochlorothiazide, Hydrodiuril, Oretic, Zide)
CombinationsAldactazide, Amiloride hydrochlorothiazide, Amlodipine besylate, valsartan hydrochlorothiazide, Atacand, Avalide, Benazepril hydrochlorothiazide, Benicar, Bisoprolol hydrochlorothiazide, Candesartan cilexetil hydrochlorothiazide, Captopril hydrochlorothiazide, Diovan, Enalapril hydrochlorothiazide, Exforge, Fosinopril hydrochlorothiazide, Hydra-zide, Hyzaar, Irbesartan hydrochlorothiazide, Lisinopril hydrochlorothiazide, Lopressor, Losartan potassium hydrochlorothiazide, Lotensin, Maxzide, Metoprolol hydrochlorothiazide, Micardis, Moexipril hydrochlorothiazide, Olmesartan medoxomil hydrochlorothiazide, Olmesartan medoxomil, amlodipine hydrochlorothiazide, Quinapril hydrochlorothiazide, Spironolactone hydrochlorothiazide, Telmisartan hydrochlorothiazide, Triamterene hydrochlorothiazide, Tribenzor, Valsartan hydrochlorothiazide, Vaseretic, Zestoretic, Ziac (discontinued: Accuretic, Aldactazide, Aldoril d50, Amiloride hydrochlorothiazide, Amlodipine besylate, valsartan hydrochlorothiazide, Amturnide, Apresazide, Apresoline-esidrix, Avalide, Benazepril hydrochlorothiazide, Bisoprolol hydrochlorothiazide, Cam-ap-es, Candesartan cilexetil hydrochlorothiazide, Capozide, Captopril hydrochlorothiazide, Dutoprol, Dyazide, Enalapril hydrochlorothiazide, Esimil, Fosinopril hydrochlorothiazide, Hydra-zide, Hydralazine hydrochloride, hydrochlorothiazide reserpine, Hydralazine hydrochloride-hydrochlorothiazide-reserpine, Hydralazine hydrochlorothiazide, Hydralazine w/ hydrochlorothiazide, Hydralazine, hydrochlorothiazide w/ reserpine, Hydrap-es, Hydro-ride, Hydro-serp, Hydrochlorothiazide w/ hydralazine, Hydrochlorothiazide w/ reserpine, Hydrochlorothiazide w/ reserpine hydralazine, Hydropres, Hydroserpine (r), Inderide, Inderide-, Irbesartan hydrochlorothiazide, Lisinopril hydrochlorothiazide, Lopressor, Losartan potassium hydrochlorothiazide, Lotensin, Methyldopa hydrochlorothiazide, Metoprolol hydrochlorothiazide, Moduretic, Moexipril hydrochlorothiazide, Monopril-hct, Normozide, Olmesartan medoxomil hydrochlorothiazide, Olmesartan medoxomil, amlodipine hydrochlorothiazide, Oreticyl, Prinzide, Propranolol & hydrochlorothiazide, Propranolol hydrochlorothiazide, Quinapril hydrochlorothiazide, Reserpine hydrochlorothiazide, Reserpine, hydralazine hydrochlorothiazide, Reserpine, hydrochlorothiazide, hydralazine, Ser-a-gen, Ser-ap-es, Serpasil-esidrix, Spironolactone hydrochlorothiazide, Spironolactone w/ hydrochlorothiazide, Tekturna, Telmisartan hydrochlorothiazide, Teveten, Timolide, Trandate, Triamterene hydrochlorothiazide, Unipres, Uniretic, Valsartan hydrochlorothiazide, Viskazide)
Drug Products
FDA
EMA
New Drug Application (NDA)
New Drug Application (NDA)
Abbreviated New Drug Application (ANDA)
Abbreviated New Drug Application (ANDA)
Hydrochlorothiazide
Tradename | Company | Number | Date | Products |
|---|---|---|---|---|
| INZIRQO | Novitium Pharma | N-219141 RX | 2025-01-28 | 1 products, RLD, RS |
| MICROZIDE | Teva | N-020504 RX | 1996-12-27 | 1 products, RLD, RS |
Show 3 discontinued
Bisoprolol fumarate
+
Hydrochlorothiazide
Hydrochlorothiazide
+
Triamterene
Tradename | Company | Number | Date | Products |
|---|---|---|---|---|
| MAXZIDE | Aurobindo Pharma | N-019129 RX | 1984-10-22 | 1 products, RLD, RS |
| MAXZIDE-25 | Aurobindo Pharma | N-019129 RX | 1988-05-13 | 1 products, RLD |
Show 1 discontinued
Hydrochlorothiazide
+
Labetalol hydrochloride
Tradename | Company | Number | Date | Products |
|---|---|---|---|---|
| TRANDATE HCT | GSK | N-019174 DISCN | 1987-04-10 | 4 products |
| NORMOZIDE | Merck & Co | N-019046 DISCN | 1987-04-06 | 4 products |
Hide discontinued
Hydrochlorothiazide
+
Telmisartan
Tradename | Company | Number | Date | Products |
|---|---|---|---|---|
| MICARDIS HCT | Boehringer Ingelheim | N-021162 RX | 2000-11-17 | 3 products, RLD |
Hydrochlorothiazide
+
Losartan potassium
Deserpidine
+
Hydrochlorothiazide
Eprosartan mesylate
+
Hydrochlorothiazide
Aliskiren hemifumarate
+
Amlodipine besylate
+
Hydrochlorothiazide
Hydralazine hydrochloride
+
Hydrochlorothiazide
Hydrochlorothiazide
+
Valsartan
Guanethidine monosulfate
+
Hydrochlorothiazide
Amlodipine besylate
+
Hydrochlorothiazide
+
Valsartan
Hydralazine hydrochloride
+
Hydrochlorothiazide
+
Reserpine
Hydrochlorothiazide
+
Reserpine
Tradename | Company | Number | Date | Products |
|---|---|---|---|---|
| HYDROPRES 25 | Merck & Co | N-011958 DISCN | 1982-01-01 | 1 products |
| HYDROPRES 50 | Merck & Co | N-011958 DISCN | 1982-01-01 | 1 products |
| SERPASIL-ESIDRIX #1 | Novartis | N-011878 DISCN | 1982-01-01 | 1 products |
| SERPASIL-ESIDRIX #2 | Novartis | N-011878 DISCN | 1982-01-01 | 1 products |
Hide discontinued
Hydrochlorothiazide
+
Pindolol
Hydrochlorothiazide
+
Irbesartan
Hydrochlorothiazide
+
Propranolol hydrochloride
Tradename | Company | Number | Date | Products |
|---|---|---|---|---|
| INDERIDE LA 80/50 | Wyeth | N-019059 DISCN | 1985-07-03 | 1 products |
| INDERIDE LA 120/50 | Wyeth | N-019059 DISCN | 1985-07-03 | 1 products |
| INDERIDE LA 160/50 | Wyeth | N-019059 DISCN | 1985-07-03 | 1 products |
| INDERIDE-40/25 | Wyeth | N-018031 DISCN | 1982-01-01 | 1 products, RLD |
| INDERIDE-80/25 | Wyeth | N-018031 DISCN | 1982-01-01 | 1 products, RLD |
Hide discontinued
Hydrochlorothiazide
+
Moexipril hydrochloride
Enalapril maleate
+
Hydrochlorothiazide
Tradename | Company | Number | Date | Products |
|---|---|---|---|---|
| VASERETIC | Bausch Health Companies | N-019221 RX | 1986-10-31 | 2 products, RLD, RS |
Hydrochlorothiazide
+
Methyldopa
Tradename | Company | Number | Date | Products |
|---|---|---|---|---|
| ALDORIL 15 | Merck & Co | N-013402 DISCN | 1982-01-01 | 1 products |
| ALDORIL 25 | Merck & Co | N-013402 DISCN | 1982-01-01 | 1 products |
| ALDORIL D30 | Merck & Co | N-013402 DISCN | 1982-01-01 | 1 products |
| ALDORIL D50 | Merck & Co | N-013402 DISCN | 1982-01-01 | 1 products |
Hide discontinued
Amiloride hydrochloride
+
Hydrochlorothiazide
Tradename | Company | Number | Date | Products |
|---|---|---|---|---|
| MODURETIC 5-50 | Merck & Co | N-018201 DISCN | 1982-01-01 | 1 products, RLD |
Hide discontinued
Hydrochlorothiazide
+
Lisinopril
Tradename | Company | Number | Date | Products |
|---|---|---|---|---|
| ZESTORETIC | Almatica Pharma | N-019888 RX | 1989-07-20 | 3 products, RLD |
Show 1 discontinued
Hydrochlorothiazide
+
Timolol maleate
Tradename | Company | Number | Date | Products |
|---|---|---|---|---|
| TIMOLIDE 10-25 | Merck & Co | N-018061 DISCN | 1982-01-01 | 1 products |
Hide discontinued
Hydrochlorothiazide
+
Quinapril hydrochloride
Hydrochlorothiazide
+
Spironolactone
Hydrochlorothiazide
+
Olmesartan medoxomil
Tradename | Company | Number | Date | Products |
|---|---|---|---|---|
| BENICAR HCT | Cosette Pharmaceuticals | N-021532 RX | 2003-06-05 | 3 products, RLD, RS |
Amlodipine besylate
+
Hydrochlorothiazide
+
Olmesartan medoxomil
Tradename | Company | Number | Date | Products |
|---|---|---|---|---|
| TRIBENZOR | Cosette Pharmaceuticals | N-200175 RX | 2010-07-23 | 5 products, RLD, RS |
Captopril
+
Hydrochlorothiazide
Tradename | Company | Number | Date | Products |
|---|---|---|---|---|
| CAPOZIDE 25/15 | Bristol Myers Squibb | N-018709 DISCN | 1984-10-12 | 1 products, RLD |
| CAPOZIDE 25/25 | Bristol Myers Squibb | N-018709 DISCN | 1984-10-12 | 1 products, RLD |
| CAPOZIDE 50/25 | Bristol Myers Squibb | N-018709 DISCN | 1984-10-12 | 1 products, RLD |
| CAPOZIDE 50/15 | Bristol Myers Squibb | N-018709 DISCN | 1984-10-12 | 1 products, RLD |
Hide discontinued
Fosinopril sodium
+
Hydrochlorothiazide
Tradename | Company | Number | Date | Products |
|---|---|---|---|---|
| MONOPRIL-HCT | Bristol Myers Squibb | N-020286 DISCN | 1994-11-30 | 2 products, RLD |
Hide discontinued
Candesartan cilexetil
+
Hydrochlorothiazide
Tradename | Company | Number | Date | Products |
|---|---|---|---|---|
| ATACAND HCT | ANI Pharmaceuticals | N-021093 RX | 2000-09-05 | 3 products, RLD |
Hydrochlorothiazide
+
Metoprolol tartrate
Tradename | Company | Number | Date | Products |
|---|---|---|---|---|
| LOPRESSOR HCT | Validus Pharmaceuticals | N-018303 RX | 1984-12-31 | 1 products, RLD |
Show 1 discontinued
Benazepril hydrochloride
+
Hydrochlorothiazide
Tradename | Company | Number | Date | Products |
|---|---|---|---|---|
| LOTENSIN HCT | Validus Pharmaceuticals | N-020033 RX | 1992-05-19 | 3 products, RLD |
Show 1 discontinued
Aliskiren hemifumarate
+
Hydrochlorothiazide
Tradename | Company | Number | Date | Products |
|---|---|---|---|---|
| TEKTURNA HCT | Noden Pharma | N-022107 DISCN | 2008-01-18 | 4 products, RLD |
Hide discontinued
Hydrochlorothiazide
+
Metoprolol succinate
Tradename | Company | Number | Date | Products |
|---|---|---|---|---|
| DUTOPROL | Concordia Laboratories | N-021956 DISCN | 2006-08-28 | 3 products, RLD |
Hide discontinued
Labels
FDA
EMA
Brand Name | Status | Last Update |
|---|---|---|
| accuretic | New Drug Application | 2023-09-18 |
| amiloride hydrochloride and hydrochlorothiazide | ANDA | 2022-12-27 |
| amlodipine, valsartan and hydrochlorothiazide | ANDA | 2024-05-17 |
| amlodipine, valsartan, hydrochlorothiazide | ANDA | 2025-06-02 |
| amlodipine,valsartan and hydrochlorothiazide | ANDA | 2025-01-09 |
| atacand hct | New Drug Application | 2020-05-07 |
| avalide | New Drug Application | 2025-10-07 |
| benazepril hydrochloride and hydrochlorothiazide | ANDA | 2025-06-16 |
| benicar hct | New Drug Application | 2023-07-12 |
| bisoprolol fumarate and hydrochlorothiazide | ANDA | 2025-09-23 |
Show 52 more
Indications
FDA
EMA
Show 24 more
Agency Specific
FDA
EMA
No data
Patent Expiration
Patent | Expires | Flag | FDA Information |
|---|---|---|---|
| Aliskiren Hemifumarate / Hydrochlorothiazide, Tekturna Hct, Noden Pharma | |||
| 8618172 | 2028-07-13 | DP | |
| Amlodipine Besylate / Hydrochlorothiazide / Valsartan, Exforge Hct, Novartis | |||
| 8101599 | 2023-05-16 | DP | |
| 8475839 | 2023-05-16 | DP | |
| Aliskiren Hemifumarate / Amlodipine Besylate / Hydrochlorothiazide, Amturnide, Novartis | |||
| 8183295 | 2023-05-16 | DP | |
ATC Codes
C: Cardiovascular system drugs
— C03: Diuretics
— C03A: Low-ceiling diuretics, thiazides
— C03AA: Thiazides, plain
— C03AA03: Hydrochlorothiazide
— C03AB: Thiazides and potassium in combination
— C03AB03: Hydrochlorothiazide and potassium
— C03AX: Thiazides, combinations with other drugs
— C03AX01: Hydrochlorothiazide, combinations
— C03E: Diuretics and potassium-sparing agents in combination
— C03EA: Low-ceiling diuretics and potassium-sparing agents
— C03EA01: Hydrochlorothiazide and potassium-sparing agents
— C09: Agents acting on the renin-angiotensin system
— C09B: Ace inhibitors, combinations
— C09BX: Ace inhibitors, other combinations in atc
— C09BX03: Ramipril, amlodipine and hydrochlorothiazide
— C09D: Angiotensin ii receptor blockers (arbs), combinations
— C09DX: Angiotensin ii receptor blockers (arbs), other combinations
— C09DX01: Valsartan, amlodipine and hydrochlorothiazide
— C09DX03: Olmesartan medoxomil, amlodipine and hydrochlorothiazide
— C09DX06: Candesartan, amlodipine and hydrochlorothiazide
— C09DX07: Irbesartan, amlodipine and hydrochlorothiazide
— C09X: Other agents acting on the renin-angiotensin system in atc
— C09XA: Renin-inhibitors
— C09XA52: Aliskiren and hydrochlorothiazide
— C09XA54: Aliskiren, amlodipine and hydrochlorothiazide
HCPCS
No data
Clinical
Clinical Trials
1328 clinical trials
View more details
Mock data
Subscribe for the real data
Subscribe for the real data
Indications Phases 4
Indication | MeSH | Ontology | ICD-10 | Ph 1 | Ph 2 | Ph 3 | Ph 4 | Other | Total |
|---|---|---|---|---|---|---|---|---|---|
| Hypertension | D006973 | EFO_0000537 | I10 | 17 | 24 | 125 | 140 | 76 | 379 |
| Leukemia | D007938 | — | C95 | 31 | 69 | 14 | 1 | 17 | 119 |
| Myelodysplastic syndromes | D009190 | — | D46 | 27 | 55 | 6 | 2 | 11 | 93 |
| Essential hypertension | D000075222 | — | I10 | 3 | 4 | 45 | 12 | 10 | 72 |
| Hematologic neoplasms | D019337 | — | — | 18 | 29 | 5 | 1 | 23 | 66 |
| Hematopoietic stem cell transplantation | D018380 | — | — | 12 | 20 | 5 | 1 | 27 | 59 |
| Lymphoma | D008223 | — | C85.9 | 16 | 32 | 4 | 1 | 9 | 57 |
| Multiple myeloma | D009101 | — | C90.0 | 11 | 21 | — | 1 | 13 | 44 |
| Anemia | D000740 | EFO_0004272 | D64.9 | 2 | 10 | 5 | 5 | 21 | 42 |
| Myeloproliferative disorders | D009196 | — | D47.1 | 10 | 25 | — | 2 | 5 | 39 |
Show 98 more
Indications Phases 3
Indication | MeSH | Ontology | ICD-10 | Ph 1 | Ph 2 | Ph 3 | Ph 4 | Other | Total |
|---|---|---|---|---|---|---|---|---|---|
| Myeloid leukemia acute | D015470 | — | C92.0 | 37 | 70 | 14 | — | 16 | 122 |
| Precursor cell lymphoblastic leukemia-lymphoma | D054198 | — | C91.0 | 16 | 47 | 8 | — | 8 | 73 |
| Myeloid leukemia | D007951 | — | C92 | 21 | 38 | 8 | — | 8 | 68 |
| Healthy volunteers/patients | — | — | — | 39 | 1 | 1 | — | 12 | 52 |
| Neoplasms | D009369 | — | C80 | 9 | 18 | 2 | — | 22 | 45 |
| Graft vs host disease | D006086 | — | D89.81 | 11 | 22 | 5 | — | 9 | 41 |
| Bcr-abl positive chronic myelogenous leukemia | D015464 | EFO_0000340 | — | 11 | 23 | 1 | — | 3 | 35 |
| Preleukemia | D011289 | — | — | 10 | 21 | 1 | — | 5 | 33 |
| Myelomonocytic leukemia chronic | D015477 | — | C93.1 | 6 | 12 | 1 | — | 2 | 19 |
| Biphenotypic leukemia acute | D015456 | — | C95.0 | 7 | 14 | 1 | — | — | 19 |
Show 81 more
Indications Phases 2
Indication | MeSH | Ontology | ICD-10 | Ph 1 | Ph 2 | Ph 3 | Ph 4 | Other | Total |
|---|---|---|---|---|---|---|---|---|---|
| Non-hodgkin lymphoma | D008228 | — | C85.9 | 13 | 24 | — | — | 6 | 37 |
| B-cell chronic lymphocytic leukemia | D015451 | — | C91.1 | 5 | 22 | — | — | 4 | 29 |
| Hodgkin disease | D006689 | — | C81 | 7 | 17 | — | — | 6 | 29 |
| Primary myelofibrosis | D055728 | — | D47.4 | 8 | 13 | — | — | 6 | 27 |
| Sickle cell anemia | D000755 | EFO_0000697 | D57 | 6 | 7 | — | — | 6 | 17 |
| Follicular lymphoma | D008224 | — | C82 | 3 | 8 | — | — | 3 | 13 |
| B-cell lymphoma marginal zone | D018442 | — | C88.4 | 3 | 7 | — | — | 3 | 12 |
| Myeloid leukemia accelerated phase | D015465 | — | — | 3 | 6 | — | — | 4 | 12 |
| Immunologic deficiency syndromes | D007153 | — | D84.9 | 1 | 3 | — | — | 8 | 12 |
| Large b-cell lymphoma diffuse | D016403 | — | C83.3 | 3 | 7 | — | — | 3 | 11 |
Show 179 more
Indications Phases 1
Indication | MeSH | Ontology | ICD-10 | Ph 1 | Ph 2 | Ph 3 | Ph 4 | Other | Total |
|---|---|---|---|---|---|---|---|---|---|
| Premature birth | D047928 | EFO_0003917 | O60 | 1 | — | — | — | 6 | 7 |
| Virus diseases | D014777 | — | B34 | 1 | — | — | — | 5 | 6 |
| Hypoxia | D000860 | — | R09.02 | 1 | — | — | — | 4 | 5 |
| Hairy cell leukemia | D007943 | — | C91.4 | 1 | — | — | — | 3 | 4 |
| Bronchiolitis obliterans | D001989 | EFO_0007183 | J44.81 | 2 | — | — | — | 1 | 3 |
| Fatigue | D005221 | — | R53.83 | 1 | — | — | — | 2 | 3 |
| Hemostatic disorders | D020141 | — | — | 1 | — | — | — | 2 | 3 |
| Back pain | D001416 | — | M54 | 1 | — | — | — | 2 | 3 |
| Therapeutic equivalency | D013810 | — | — | 2 | — | — | — | — | 2 |
| Fasting | D005215 | EFO_0002756 | — | 2 | — | — | — | — | 2 |
Show 57 more
Indications Without Phase
Indication | MeSH | Ontology | ICD-10 | Ph 1 | Ph 2 | Ph 3 | Ph 4 | Other | Total |
|---|---|---|---|---|---|---|---|---|---|
| Ulcer | D014456 | MPATH_579 | — | — | — | — | — | 8 | 8 |
| Breast neoplasms | D001943 | EFO_0003869 | C50 | — | — | — | — | 5 | 5 |
| Varicose ulcer | D014647 | — | — | — | — | — | — | 5 | 5 |
| Foot ulcer | D016523 | — | — | — | — | — | — | 5 | 5 |
| Postoperative pain | D010149 | — | G89.18 | — | — | — | — | 4 | 4 |
| Leg ulcer | D007871 | — | — | — | — | — | — | 4 | 4 |
| Pathologic constriction | D003251 | — | — | — | — | — | — | 4 | 4 |
| Neutrophilic leukemia chronic | D015467 | — | D47.1 | — | — | — | — | 3 | 3 |
| Scoliosis | D012600 | EFO_0004273 | M41 | — | — | — | — | 3 | 3 |
| Spinal stenosis | D013130 | EFO_0007490 | M48.0 | — | — | — | — | 3 | 3 |
Show 241 more
Epidemiology
Epidemiological information for investigational and approved indications
View more details
Drug
General
| Drug common name | Hydrochlorothiazide |
| INN | hydrochlorothiazide |
| Description | Hydrochlorothiazide is a benzothiadiazine that is 3,4-dihydro-2H-1,2,4-benzothiadiazine 1,1-dioxide substituted by a chloro group at position 6 and a sulfonamide at 7. It is diuretic used for the treatment of hypertension and congestive heart failure. It has a role as a xenobiotic, an environmental contaminant, a diuretic and an antihypertensive agent. It is a benzothiadiazine, a sulfonamide and an organochlorine compound. |
| Classification | Small molecule |
| Drug class | diuretics (thiazide derivatives) |
| Image (chem structure or protein) |  |
| Structure (InChI/SMILES or Protein Sequence) | NS(=O)(=O)c1cc2c(cc1Cl)NCNS2(=O)=O |
Identifiers
| PDB | — |
| CAS-ID | 58-93-5 |
| RxCUI | — |
| ChEMBL ID | CHEMBL435 |
| ChEBI ID | 5778 |
| PubChem CID | 3639 |
| DrugBank | DB00999 |
| UNII ID | 0J48LPH2TH (ChemIDplus, GSRS) |
Target
No data
Variants
No data
Financial
Revenue by drug
$
€
£
₣
Exforge – Novartis
Mock data
Subscribe for the real data
Subscribe for the real data
Mock data
Subscribe for the real data
Subscribe for the real data
Diovan – Novartis
Mock data
Subscribe for the real data
Subscribe for the real data
Mock data
Subscribe for the real data
Subscribe for the real data
Atacand – AstraZeneca
Mock data
Subscribe for the real data
Subscribe for the real data
Mock data
Subscribe for the real data
Subscribe for the real data
Tabular view
Estimated US medical usage
Hydrochlorothiazide
+
Aliskiren
Total medical expenditures per year (USD, in millions)
Mock data
Subscribe for the real data
Subscribe for the real data
Number of persons purchased
Mock data
Subscribe for the real data
Subscribe for the real data
Number of purchases
Mock data
Subscribe for the real data
Subscribe for the real data
Refill frequency
Mock data
Subscribe for the real data
Subscribe for the real data
Price per prescription (USD)
Mock data
Subscribe for the real data
Subscribe for the real data
Hydrochlorothiazide
+
Amiloride
Total medical expenditures per year (USD, in millions)
Mock data
Subscribe for the real data
Subscribe for the real data
Number of persons purchased
Mock data
Subscribe for the real data
Subscribe for the real data
Number of purchases
Mock data
Subscribe for the real data
Subscribe for the real data
Refill frequency
Mock data
Subscribe for the real data
Subscribe for the real data
Price per prescription (USD)
Mock data
Subscribe for the real data
Subscribe for the real data
Hydrochlorothiazide
+
Amlodipine
+
Olmesartan
Total medical expenditures per year (USD, in millions)
Mock data
Subscribe for the real data
Subscribe for the real data
Number of persons purchased
Mock data
Subscribe for the real data
Subscribe for the real data
Number of purchases
Mock data
Subscribe for the real data
Subscribe for the real data
Refill frequency
Mock data
Subscribe for the real data
Subscribe for the real data
Price per prescription (USD)
Mock data
Subscribe for the real data
Subscribe for the real data
Hydrochlorothiazide
+
Amlodipine
+
Valsartan
Total medical expenditures per year (USD, in millions)
Mock data
Subscribe for the real data
Subscribe for the real data
Number of persons purchased
Mock data
Subscribe for the real data
Subscribe for the real data
Number of purchases
Mock data
Subscribe for the real data
Subscribe for the real data
Refill frequency
Mock data
Subscribe for the real data
Subscribe for the real data
Price per prescription (USD)
Mock data
Subscribe for the real data
Subscribe for the real data
Hydrochlorothiazide
+
Benazepril
Total medical expenditures per year (USD, in millions)
Mock data
Subscribe for the real data
Subscribe for the real data
Number of persons purchased
Mock data
Subscribe for the real data
Subscribe for the real data
Number of purchases
Mock data
Subscribe for the real data
Subscribe for the real data
Refill frequency
Mock data
Subscribe for the real data
Subscribe for the real data
Price per prescription (USD)
Mock data
Subscribe for the real data
Subscribe for the real data
Hydrochlorothiazide
+
Bisoprolol
Total medical expenditures per year (USD, in millions)
Mock data
Subscribe for the real data
Subscribe for the real data
Number of persons purchased
Mock data
Subscribe for the real data
Subscribe for the real data
Number of purchases
Mock data
Subscribe for the real data
Subscribe for the real data
Refill frequency
Mock data
Subscribe for the real data
Subscribe for the real data
Price per prescription (USD)
Mock data
Subscribe for the real data
Subscribe for the real data
Hydrochlorothiazide
+
Captopril
Total medical expenditures per year (USD, in millions)
Mock data
Subscribe for the real data
Subscribe for the real data
Number of persons purchased
Mock data
Subscribe for the real data
Subscribe for the real data
Number of purchases
Mock data
Subscribe for the real data
Subscribe for the real data
Refill frequency
Mock data
Subscribe for the real data
Subscribe for the real data
Price per prescription (USD)
Mock data
Subscribe for the real data
Subscribe for the real data
Hydrochlorothiazide
+
Enalapril
Total medical expenditures per year (USD, in millions)
Mock data
Subscribe for the real data
Subscribe for the real data
Number of persons purchased
Mock data
Subscribe for the real data
Subscribe for the real data
Number of purchases
Mock data
Subscribe for the real data
Subscribe for the real data
Refill frequency
Mock data
Subscribe for the real data
Subscribe for the real data
Price per prescription (USD)
Mock data
Subscribe for the real data
Subscribe for the real data
Hydrochlorothiazide
+
Eprosartan
Total medical expenditures per year (USD, in millions)
Mock data
Subscribe for the real data
Subscribe for the real data
Number of persons purchased
Mock data
Subscribe for the real data
Subscribe for the real data
Number of purchases
Mock data
Subscribe for the real data
Subscribe for the real data
Refill frequency
Mock data
Subscribe for the real data
Subscribe for the real data
Price per prescription (USD)
Mock data
Subscribe for the real data
Subscribe for the real data
Hydrochlorothiazide
+
Fosinopril
Total medical expenditures per year (USD, in millions)
Mock data
Subscribe for the real data
Subscribe for the real data
Number of persons purchased
Mock data
Subscribe for the real data
Subscribe for the real data
Number of purchases
Mock data
Subscribe for the real data
Subscribe for the real data
Refill frequency
Mock data
Subscribe for the real data
Subscribe for the real data
Price per prescription (USD)
Mock data
Subscribe for the real data
Subscribe for the real data
Hydrochlorothiazide
+
Hydralazine
Total medical expenditures per year (USD, in millions)
Mock data
Subscribe for the real data
Subscribe for the real data
Number of persons purchased
Mock data
Subscribe for the real data
Subscribe for the real data
Number of purchases
Mock data
Subscribe for the real data
Subscribe for the real data
Refill frequency
Mock data
Subscribe for the real data
Subscribe for the real data
Price per prescription (USD)
Mock data
Subscribe for the real data
Subscribe for the real data
Hydrochlorothiazide
+
Hydralazine
+
Reserpine
Total medical expenditures per year (USD, in millions)
Mock data
Subscribe for the real data
Subscribe for the real data
Number of persons purchased
Mock data
Subscribe for the real data
Subscribe for the real data
Number of purchases
Mock data
Subscribe for the real data
Subscribe for the real data
Refill frequency
Mock data
Subscribe for the real data
Subscribe for the real data
Price per prescription (USD)
Mock data
Subscribe for the real data
Subscribe for the real data
Hydrochlorothiazide
Total medical expenditures per year (USD, in millions)
Mock data
Subscribe for the real data
Subscribe for the real data
Number of persons purchased
Mock data
Subscribe for the real data
Subscribe for the real data
Number of purchases
Mock data
Subscribe for the real data
Subscribe for the real data
Refill frequency
Mock data
Subscribe for the real data
Subscribe for the real data
Price per prescription (USD)
Mock data
Subscribe for the real data
Subscribe for the real data
Hydrochlorothiazide
+
Irbesartan
Total medical expenditures per year (USD, in millions)
Mock data
Subscribe for the real data
Subscribe for the real data
Number of persons purchased
Mock data
Subscribe for the real data
Subscribe for the real data
Number of purchases
Mock data
Subscribe for the real data
Subscribe for the real data
Refill frequency
Mock data
Subscribe for the real data
Subscribe for the real data
Price per prescription (USD)
Mock data
Subscribe for the real data
Subscribe for the real data
Hydrochlorothiazide
+
Lisinopril
Total medical expenditures per year (USD, in millions)
Mock data
Subscribe for the real data
Subscribe for the real data
Number of persons purchased
Mock data
Subscribe for the real data
Subscribe for the real data
Number of purchases
Mock data
Subscribe for the real data
Subscribe for the real data
Refill frequency
Mock data
Subscribe for the real data
Subscribe for the real data
Price per prescription (USD)
Mock data
Subscribe for the real data
Subscribe for the real data
Hydrochlorothiazide
+
Losartan
Total medical expenditures per year (USD, in millions)
Mock data
Subscribe for the real data
Subscribe for the real data
Number of persons purchased
Mock data
Subscribe for the real data
Subscribe for the real data
Number of purchases
Mock data
Subscribe for the real data
Subscribe for the real data
Refill frequency
Mock data
Subscribe for the real data
Subscribe for the real data
Price per prescription (USD)
Mock data
Subscribe for the real data
Subscribe for the real data
Hydrochlorothiazide
+
Methyldopa
Total medical expenditures per year (USD, in millions)
Mock data
Subscribe for the real data
Subscribe for the real data
Number of persons purchased
Mock data
Subscribe for the real data
Subscribe for the real data
Number of purchases
Mock data
Subscribe for the real data
Subscribe for the real data
Refill frequency
Mock data
Subscribe for the real data
Subscribe for the real data
Price per prescription (USD)
Mock data
Subscribe for the real data
Subscribe for the real data
Hydrochlorothiazide
+
Metoprolol
Total medical expenditures per year (USD, in millions)
Mock data
Subscribe for the real data
Subscribe for the real data
Number of persons purchased
Mock data
Subscribe for the real data
Subscribe for the real data
Number of purchases
Mock data
Subscribe for the real data
Subscribe for the real data
Refill frequency
Mock data
Subscribe for the real data
Subscribe for the real data
Price per prescription (USD)
Mock data
Subscribe for the real data
Subscribe for the real data
Hydrochlorothiazide
+
Moexipril
Total medical expenditures per year (USD, in millions)
Mock data
Subscribe for the real data
Subscribe for the real data
Number of persons purchased
Mock data
Subscribe for the real data
Subscribe for the real data
Number of purchases
Mock data
Subscribe for the real data
Subscribe for the real data
Refill frequency
Mock data
Subscribe for the real data
Subscribe for the real data
Price per prescription (USD)
Mock data
Subscribe for the real data
Subscribe for the real data
Hydrochlorothiazide
+
Olmesartan
Total medical expenditures per year (USD, in millions)
Mock data
Subscribe for the real data
Subscribe for the real data
Number of persons purchased
Mock data
Subscribe for the real data
Subscribe for the real data
Number of purchases
Mock data
Subscribe for the real data
Subscribe for the real data
Refill frequency
Mock data
Subscribe for the real data
Subscribe for the real data
Price per prescription (USD)
Mock data
Subscribe for the real data
Subscribe for the real data
Hydrochlorothiazide
+
Propranolol
Total medical expenditures per year (USD, in millions)
Mock data
Subscribe for the real data
Subscribe for the real data
Number of persons purchased
Mock data
Subscribe for the real data
Subscribe for the real data
Number of purchases
Mock data
Subscribe for the real data
Subscribe for the real data
Refill frequency
Mock data
Subscribe for the real data
Subscribe for the real data
Price per prescription (USD)
Mock data
Subscribe for the real data
Subscribe for the real data
Hydrochlorothiazide
+
Quinapril
Total medical expenditures per year (USD, in millions)
Mock data
Subscribe for the real data
Subscribe for the real data
Number of persons purchased
Mock data
Subscribe for the real data
Subscribe for the real data
Number of purchases
Mock data
Subscribe for the real data
Subscribe for the real data
Refill frequency
Mock data
Subscribe for the real data
Subscribe for the real data
Price per prescription (USD)
Mock data
Subscribe for the real data
Subscribe for the real data
Hydrochlorothiazide
+
Reserpine
Total medical expenditures per year (USD, in millions)
Mock data
Subscribe for the real data
Subscribe for the real data
Number of persons purchased
Mock data
Subscribe for the real data
Subscribe for the real data
Number of purchases
Mock data
Subscribe for the real data
Subscribe for the real data
Refill frequency
Mock data
Subscribe for the real data
Subscribe for the real data
Price per prescription (USD)
Mock data
Subscribe for the real data
Subscribe for the real data
Hydrochlorothiazide
+
Spironolactone
Total medical expenditures per year (USD, in millions)
Mock data
Subscribe for the real data
Subscribe for the real data
Number of persons purchased
Mock data
Subscribe for the real data
Subscribe for the real data
Number of purchases
Mock data
Subscribe for the real data
Subscribe for the real data
Refill frequency
Mock data
Subscribe for the real data
Subscribe for the real data
Price per prescription (USD)
Mock data
Subscribe for the real data
Subscribe for the real data
Hydrochlorothiazide
+
Telmisartan
Total medical expenditures per year (USD, in millions)
Mock data
Subscribe for the real data
Subscribe for the real data
Number of persons purchased
Mock data
Subscribe for the real data
Subscribe for the real data
Number of purchases
Mock data
Subscribe for the real data
Subscribe for the real data
Refill frequency
Mock data
Subscribe for the real data
Subscribe for the real data
Price per prescription (USD)
Mock data
Subscribe for the real data
Subscribe for the real data
Hydrochlorothiazide
+
Timolol
Total medical expenditures per year (USD, in millions)
Mock data
Subscribe for the real data
Subscribe for the real data
Number of persons purchased
Mock data
Subscribe for the real data
Subscribe for the real data
Number of purchases
Mock data
Subscribe for the real data
Subscribe for the real data
Refill frequency
Mock data
Subscribe for the real data
Subscribe for the real data
Price per prescription (USD)
Mock data
Subscribe for the real data
Subscribe for the real data
Hydrochlorothiazide
+
Triamterene
Total medical expenditures per year (USD, in millions)
Mock data
Subscribe for the real data
Subscribe for the real data
Number of persons purchased
Mock data
Subscribe for the real data
Subscribe for the real data
Number of purchases
Mock data
Subscribe for the real data
Subscribe for the real data
Refill frequency
Mock data
Subscribe for the real data
Subscribe for the real data
Price per prescription (USD)
Mock data
Subscribe for the real data
Subscribe for the real data
Hydrochlorothiazide
+
Valsartan
Total medical expenditures per year (USD, in millions)
Mock data
Subscribe for the real data
Subscribe for the real data
Number of persons purchased
Mock data
Subscribe for the real data
Subscribe for the real data
Number of purchases
Mock data
Subscribe for the real data
Subscribe for the real data
Refill frequency
Mock data
Subscribe for the real data
Subscribe for the real data
Price per prescription (USD)
Mock data
Subscribe for the real data
Subscribe for the real data
Tabular view
Trends
PubMed Central
Top Terms for Disease or Syndrome:
Mock data
Subscribe for the real data
Subscribe for the real data
Additional graphs summarizing 94,852 documents
View more details
Safety
Black-box Warning
Black-box warning for: Accuretic, Amlodipine, valsartan and hydrochlorothiazide, Amlodipine, valsartan, hydrochlorothiazide, Amlodipine,valsartan and hydrochlorothiazide, Atacand hct, Avalide, Benazepril hydrochloride and hydrochlorothiazide, Benicar hct, Captopril and hydrochlorothiazide, Citalopram hydrobromide, Clopidogrel, Diovan hct, Enalapril maleate and hydrochlorothiazide, Exforge hct, Fosinopril sodium and hydrochlorothiazide, Hyzaar, Irbesartan and hydrochlorothiazide, Lisinopril, Lisinopril and hctz, Lisinopril and hydrochlorothiazide, Lisinopril with hydrochlorothiazide, Lisinopril-hydrochlorothiazide, Losartan potassium and hydrochlorothiazide, Losartan potassium and hydrochlorothiazide, Losartan potassium and hydrochlorothiazide losartan potassium hctz, Lotensin, Lotensin hct, Micardis hct, Olmesartan medoxomil / amlodipine besylate / hydrochlorothiazide, Olmesartan medoxomil amlodipine and hydrochlorothiazide, Olmesartan medoxomil and amlodipine besylate and hydrochlorothiazide, Olmesartan medoxomil and hydrochlorothiazide, Olmesartan medoxomil, amlodipine and hydrochlorothiazide, Olmesartan medoxomil, amlodipine and hydrochlorothiazide 20/5/12.5 mg, Olmesartan medoxomil, amlodipine and hydrochlorothiazide 20/5/12.5 mg olmesartan medoxomil, amlodipine and hydrochlorothiazide 40/10/12.5 mg olmesa..., Olmesartan medoxomil-hydrochlorothiazide, Quinapril and hydrochlorothiazide 20/12.5 quinapril and hydrochlorothiazide 10/12.5 quinapril and hydrochlorothiazide 20/25, Quinapril and hydrochlorothiazide, Quinapril and hydrochlorothiazide 10/12.5, Quinapril hcl and hydrochlorothiazide, Quinapril hydrochloride and hydrochlorothiazide, Tekturna hct, Telmisartan and hydrochlorothiazide, Teveten hct, Tribenzor, Valsartan and hydrochlorothiazide, Vaseretic, Zestoretic
Adverse Events
Top Adverse Reactions
Mock data
Subscribe for the real data
Subscribe for the real data
100,363 adverse events reported
View more details
© 2020-2025 Collaborative Drug Discovery Inc. (CDD) | Terms of Use